[English] 日本語

- PDB-4olz: Crystal structure of antibody VRC07-G54W in complex with clade A/... -
+
Open data
-
Basic information
Entry | Database: PDB / ID: 4olz | ||||||
---|---|---|---|---|---|---|---|
Title | Crystal structure of antibody VRC07-G54W in complex with clade A/E 93TH057 HIV-1 gp120 core | ||||||
![]() |
| ||||||
![]() | VIRAL PROTEIN/IMMUNE SYSTEM / VRC07 antibody / Passive transfer / Neutralization / In vivo protection / Autoreactivity / Lentiviral infection / Enhanced potency / HIV-1 gp120 / VRC07-G54W / VIRAL PROTEIN-IMMUNE SYSTEM complex | ||||||
Function / homology | ![]() positive regulation of plasma membrane raft polarization / positive regulation of receptor clustering / host cell endosome membrane / clathrin-dependent endocytosis of virus by host cell / viral protein processing / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / : / viral envelope / virion attachment to host cell ...positive regulation of plasma membrane raft polarization / positive regulation of receptor clustering / host cell endosome membrane / clathrin-dependent endocytosis of virus by host cell / viral protein processing / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / : / viral envelope / virion attachment to host cell / host cell plasma membrane / virion membrane / structural molecule activity / membrane Similarity search - Function | ||||||
Biological species | ![]() ![]() ![]() | ||||||
Method | ![]() ![]() ![]() | ||||||
![]() | Kwon, Y.D. / Kwong, P.D. | ||||||
![]() | ![]() Title: Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo. Authors: Rudicell, R.S. / Kwon, Y.D. / Ko, S.Y. / Pegu, A. / Louder, M.K. / Georgiev, I.S. / Wu, X. / Zhu, J. / Boyington, J.C. / Chen, X. / Shi, W. / Yang, Z.Y. / Doria-Rose, N.A. / McKee, K. / ...Authors: Rudicell, R.S. / Kwon, Y.D. / Ko, S.Y. / Pegu, A. / Louder, M.K. / Georgiev, I.S. / Wu, X. / Zhu, J. / Boyington, J.C. / Chen, X. / Shi, W. / Yang, Z.Y. / Doria-Rose, N.A. / McKee, K. / O'Dell, S. / Schmidt, S.D. / Chuang, G.Y. / Druz, A. / Soto, C. / Yang, Y. / Zhang, B. / Zhou, T. / Todd, J.P. / Lloyd, K.E. / Eudailey, J. / Roberts, K.E. / Donald, B.R. / Bailer, R.T. / Ledgerwood, J. / Mullikin, J.C. / Shapiro, L. / Koup, R.A. / Graham, B.S. / Nason, M.C. / Connors, M. / Haynes, B.F. / Rao, S.S. / Roederer, M. / Kwong, P.D. / Mascola, J.R. / Nabel, G.J. | ||||||
History |
|
-
Structure visualization
Structure viewer | Molecule: ![]() ![]() |
---|
-
Downloads & links
-
Download
PDBx/mmCIF format | ![]() | 330.7 KB | Display | ![]() |
---|---|---|---|---|
PDB format | ![]() | 267.7 KB | Display | ![]() |
PDBx/mmJSON format | ![]() | Tree view | ![]() | |
Others | ![]() |
-Validation report
Summary document | ![]() | 477.1 KB | Display | ![]() |
---|---|---|---|---|
Full document | ![]() | 485.8 KB | Display | |
Data in XML | ![]() | 31.4 KB | Display | |
Data in CIF | ![]() | 44.2 KB | Display | |
Arichive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
Related structure data | ![]() 4oluC ![]() 4olvC ![]() 4olwC ![]() 4olxC ![]() 4olyC ![]() 4om0C ![]() 4om1C ![]() 3ngbS C: citing same article ( S: Starting model for refinement |
---|---|
Similar structure data |
-
Links
-
Assembly
Deposited unit | ![]()
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
Unit cell |
|
-
Components
#1: Protein | Mass: 39211.434 Da / Num. of mol.: 1 / Fragment: UNP RESIDUES 43-122, 201-303, 325-486 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() ![]() | ||||||
---|---|---|---|---|---|---|---|
#2: Antibody | Mass: 25053.383 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() Description: Codon-optimized human antibody heavy chain of VRC01 Gene: Heavy chain / Plasmid: pVRC8400 / Cell line (production host): HEK293F / Production host: ![]() | ||||||
#3: Antibody | Mass: 23102.570 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() Description: Codon-optimized human antibody light chain of VRC01 Gene: Light chain / Plasmid: pVRC8400 / Cell line (production host): HEK293F / Production host: ![]() | ||||||
#4: Sugar | ChemComp-NAG / #5: Water | ChemComp-HOH / | Has protein modification | Y | Sequence details | THE V1/V2 REGIONS IN CHAIN G WAS REPLACED BY G81, G82. THE V3 REGION IN CHAIN G WAS REPLACED BY THE ...THE V1/V2 REGIONS IN CHAIN G WAS REPLACED BY G81, G82. THE V3 REGION IN CHAIN G WAS REPLACED BY THE REMAINING LINKER GGSGSG | |
-Experimental details
-Experiment
Experiment | Method: ![]() |
---|
-
Sample preparation
Crystal | Density Matthews: 2.91 Å3/Da / Density % sol: 57.78 % |
---|---|
Crystal grow | Temperature: 293 K / Method: vapor diffusion, hanging drop / pH: 8.5 Details: 14% PEG 4000, 0.2M Sodium Acetate, 0.1M Tris 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K |
-Data collection
Diffraction | Mean temperature: 100 K |
---|---|
Diffraction source | Source: ![]() ![]() ![]() |
Detector | Type: MARMOSAIC 225 mm CCD / Detector: CCD / Date: Feb 6, 2012 |
Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
Radiation wavelength | Wavelength: 1 Å / Relative weight: 1 |
Reflection | Resolution: 2.1→50 Å / Num. all: 60390 / Num. obs: 44387 / % possible obs: 73.5 % / Observed criterion σ(F): 0 / Observed criterion σ(I): 0 / Redundancy: 8.4 % / Biso Wilson estimate: 37 Å2 / Rmerge(I) obs: 0.093 / Rsym value: 0.072 / Net I/σ(I): 22 |
Reflection shell | Resolution: 2.1→2.14 Å / Redundancy: 5 % / Rmerge(I) obs: 0.751 / Mean I/σ(I) obs: 1.7 / Rsym value: 0.615 / % possible all: 40.8 |
-
Processing
Software |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Refinement | Method to determine structure: ![]() Starting model: PDB entry 3NGB Resolution: 2.1→24.993 Å / SU ML: 0.3 / σ(F): 1.33 / Phase error: 32.96 / Stereochemistry target values: ML
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refinement step | Cycle: LAST / Resolution: 2.1→24.993 Å
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refine LS restraints |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LS refinement shell |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refinement TLS params. | Method: refined / Refine-ID: X-RAY DIFFRACTION
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refinement TLS group |
|